Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry
对于晚期 HER2 阴性食管胃腺癌，是否存在首选的铂类和氟尿嘧啶类化疗方案？来自 AGAMENON-SEOM 注册研究的 1293 例患者的启示
期刊:Clinical & Translational Oncology
影响因子:2.5
doi:10.1007/s12094-024-03388-6
Arias-Martinez, Aranzazu; Martínez de Castro, Eva; Gallego, Javier; Arrazubi, Virginia; Custodio, Ana; Fernández Montes, Ana; Diez, Marc; Hernandez, Raquel; Limón, María Luisa; Cano, Juana María; Vidal-Tocino, Rosario; Macias, Ismael; Visa, Laura; Martin Richard, Marta; Sauri, Tamara; Hierro, Cinta; Gil, Mireia; Cerda, Paula; Martínez Moreno, Elia; Martínez Lago, Nieves; Mérida-García, Antonio José; Gómez González, Lucía; García Navalón, Francisco Javier; Ruiz Martín, Maribel; Marín, Gema; López-López, Flora; Ruperez Blanco, Ana Belen; Fernández, Alejandro Francisco; Jimenez-Fonseca, Paula; Carmona-Bayonas, Alberto; Alvarez-Manceñido, Felipe
